# Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye

> **NCT05193331** · NA · UNKNOWN · sponsor: **He Eye Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Diabetic Eye Problems

## Interventions

- **DRUG:** 3% Diquafosol tetrasodium

## Key facts

- **NCT ID:** NCT05193331
- **Lead sponsor:** He Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-11-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193331, "Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05193331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*